24.8 C
New York
Saturday, June 6, 2026

Tag: trademarks

Data at ADA 2026 Highlights Key Findings from Clinical and Real‑World Studies of MannKind’s Afrezza® (Inhaled Insulin) Across Pediatric Care, Pregnancy, and Use with...

Data at ADA 2026 Highlights Key Findings from Clinical and Real‑World Studies of Afrezza® (Inhaled Insulin) Across Pediatric Care, Pregnancy, and AID Use

Primax Advances AI Conference Solutions with Qualcomm-Powered Edge AI Platforms

Combining AI video collaboration, professional audio expertise, MDEP-ready development, and ODM+ integration to enable next-generation intelligent meeting spacesTAIPEI, June 4, 2026 /PRNewswire/ -- Primax Electronics...

TCL Applies its Award Winning QD-Mini LED Display Technology to Level Up Premium Gaming Monitors

Delivering the Ultimate AAA Gameplay Experience, Display Leader Introduces Three New QD-Mini LED Gaming MonitorsIRVINE, Calif., June 4, 2026 /PRNewswire/ -- TCL®, one of the world's...

Emergent BioSolutions Supports Victoria’s Voice Foundation’s National Naloxone Awareness Day to Help Save Lives from Opioid Overdose

Efforts focus on increasing awareness, expanding access to lifesaving NARCAN® Nasal Spray and reaching more communities with educational initiatives and resources
Efforts focus on increasing awareness, expanding access to lifesaving NARCAN® Nasal Spray and reaching more communities with educational initiatives and resources

Share Buyback Transaction Details May 28 – June 3, 2026

PRESS RELEASE                                        

Diversified Royalty Corp. Announces June 2026 Cash Dividend

VANCOUVER, British Columbia, June 03, 2026 (GLOBE NEWSWIRE) -- Diversified Royalty Corp. (TSX: DIV, DIV.DB.A and DIV.DB.B) (the “Corporation” or “DIV”) is pleased to announce that its board of directors has approved a cash dividend of $0.02375 per common share for the period of June 1, 2026 to June 30, 2026, which is equal to $0.285 per common share on an annualized basis. The dividend will be paid on June 30, 2026 to shareholders of record as of the close of business on June 15, 2026.

Karyopharm to Participate in Webcast Featuring Endometrial Cancer Key Opinion Leader on June 8, 2026

NEWTON, Mass., June 3, 2026 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that it...

Wesco Ranks #195 in 2026 Fortune 500® List

PITTSBURGH, June 3, 2026 /PRNewswire/ -- Wesco International (NYSE: WCC), a leading provider of business-to-business distribution, logistics services and supply chain solutions, announces its inclusion...

ePlus Demonstrates Enterprise-Grade Agentic AI Platform for Autonomous IT and Security Operations at Cisco Live

Unified Technology from ePlus, NVIDIA and Cisco Provides a Self-Contained, Fast-Acting and Secure SolutionHERNDON, Va., June 3, 2026 /PRNewswire/ -- ePlus inc. (NASDAQ NGS:...

AT&T Launches Simple Fiber Plans: Built for More, Sold for Less

AT&T is once again simplifying pricing for customers -- this time for home internet -- with a streamlined fiber lineup delivering big savings for...

AT&T Launches Simple Fiber Plans: Built for More, Sold for Less

AT&T is once again simplifying pricing for customers — this time for home internet — with a streamlined fiber lineup delivering big savings for...

MannKind Enters Data-Rich Development Period with Completion of Randomization in Phase 1b INFLO-1 Study and Enrollment of First Patient in Phase 2 INFLO-2 Trial...

MannKind Enters Data-Rich Development Period with Completion of Randomization in Phase 1b INFLO-1 Study and Enrollment of First Patient in Phase 2 INFLO-2

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsTrademarks